Indication
Pyridoxine deficiency
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate. Read more about Pyridoxine deficiency
35 drugs 32 manufacturers
Drugs that treat it
Common Pyridoxine deficiency therapies.
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE (VITAMIN B6) (pyridoxine HCl (vitamin B6))
PYRIDOXINE HCL (pyridoxine HCl (vitamin B6))
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonPyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate.
The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid.
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid.
Clinical manifestations typically include peripheral neuropathy, altered mental status, and intractable seizures, alongside microcytic or sideroblastic anemia, glossitis, cheilosis, and seborrheic dermatitis.
- nih.gov
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid
- nih.gov
Pyridoxine deficiency is a nutritional and metabolic disorder characterized by inadequate tissue levels of vitamin B6 and its biologically active coenzyme form, pyridoxal 5'-phosphate
- msdmanuals.com
The condition predominantly affects the neurological, dermatologic, and hematologic systems across various populations, often arising secondary to malabsorption, chronic alcohol use disorder, end-stage renal disease, or the use of pyridoxine-inactivating medications such as isoniazid Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid Clinical manifestations typically include peripheral...
- nih.gov
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid Clinical manifestations typically include peripheral neuropathy, altered mental status, and intractable seizures, alongside microcytic or sideroblastic anemia, glossitis, cheilosis, and seborrheic dermatitis
- nih.gov
Pathophysiologically, impaired coenzyme activity disrupts amino acid metabolism, heme biosynthesis, and neurotransmitter synthesis—notably gamma-aminobutyric acid
Personalize your experience
Follow Pyridoxine deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.